Search Login Register
1-dodecylpyridoxal
(PLD)
Summary
Also Known As:
PLD; 1-dodecylpyridoxal bromide; 1-dodecylpyridoxal chloride; Pyridinium, 1-dodecyl-4-formyl-3-hydroxy-5-(hydroxymethyl)-2-methyl-, chloride
Networked: 896
relevant articles (80 outcomes,
206 trials/studies)
for this Bio-Agent
Key Diseases for which 1-dodecylpyridoxal is
Relevant
-
Neoplasms (Cancer)
:
19 outcomes 33 studies in 194 results
-
Ovarian Neoplasms (Ovarian Cancer)
:
18 outcomes 48 studies in 112 results
-
Breast Neoplasms (Breast Cancer)
:
14 outcomes 30 studies in 87 results
-
Neoplasm Metastasis (Metastasis)
:
4 outcomes 4 studies in 21 results
-
Disease Progression
:
4 outcomes 2 studies in 22 results
Show All >>
Drugs Related to 1-dodecylpyridoxal
-
pegylated liposomal doxorubicin
-
Doxorubicin (Adriamycin)
-
Platinum
-
Carboplatin (JM8)
-
trabectedin (ecteinascidin 743)
-
Polycystic liver disease
-
Paclitaxel (Taxol)
-
bortezomib (Velcade)
-
docetaxel (Taxotere)
-
Vincristine (Oncovin)
Show All >>
Therapies Related to 1-dodecylpyridoxal
-
Drug Therapy (Chemotherapy)
-
Heterologous Transplantation (Xenotransplantation)
-
Intravenous Injections
-
Therapeutics
-
Renal Replacement Therapy (Therapies, Renal Replacement)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.